Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Azzak34on Oct 12, 2023 10:29am
91 Views
Post# 35680444

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Example of details involved in acquisition talks: like ONCY

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Example of details involved in acquisition talks: like ONCY I've stated as much myself. Management has been atrocious in communication and shareholder value, that's inarguable. But the daily barage of FUD will not raise the SP. It only hurts us all collectively as negativity among shareholders about upcoming data releases etc only bolsters the bashers case. It's totally self destructive and incredibly weak. If you're not happy you have the ability to sell and go away. Most of us are holding on for the science and likelihood of the payday that those results will bring, despite any perceived ineptitude by the board. The science is unequivocal. The whining is so pathetic! You don't have to hold these shares. Just put your money elsewhere. 
<< Previous
Bullboard Posts
Next >>